Long-term impact of sarcopenia on functional decline and mortality in community-dwelling older adults: a systematic review and meta-analysis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: Sarcopenia is an age-related syndrome characterized by progressive loss of muscle mass and function. While it is considered a key predictor of adverse health outcomes, comprehensive evidence regarding its long-term impact on functional decline and mortality in community-dwelling older adults remains limited. Objective: To evaluate the longitudinal association between baseline sarcopenia and risks of functional decline and all-cause mortality among community-dwelling older adults, with subgroup analyses based on methods of sarcopenia assessment and domains of functional decline. Methods: We conducted a systematic review and meta-analysis following PRISMA 2020 and MOOSE guidelines. Seven databases were searched from inception to September 30 th , 2025. We included cohort studies of older adults aged 60 years and above, with sarcopenia defined by recognized criteria, and reporting effect estimates for functional decline or mortality with follow-up for 1 year or longer. A meta-analysis based on heterogeneity was conducted using either common or random-effects models. Results: A total of 39 studies involving 76151 participants were included. Sarcopenia was significantly associated with an increased risk of all-cause mortality (29 publications, OR = 1.79, 95%CI: 1.55~2.06) and functional decline (16 publications, OR = 1.90, 95%CI: 1.55~2.32). Subgroup analyses revealed consistent associations across different muscle mass assessment methods (DXA, BIA, and CT). Notably, sarcopenia was associated with both physical (OR = 1.91, 95%CI: 1.52~2.40) and cognitive/psychological functional decline (OR = 2.03, 95%CI: 1.35~3.05). Heterogeneity was moderate to high but did not substantially alter the results in sensitivity analyses. Conclusion: This meta-analysis confirms that sarcopenia significantly predicts long-term functional decline and mortality in community-dwelling older adults, with robust associations across multiple muscle mass measurement methods and functional domains. These findings highlight the importance of standardized sarcopenia screening and early intervention to mitigate long-term functional impairment and mortality risk in aging populations. Clinical trial registration: PROSPERO (ID CRD42024595362).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With increasing age, the prevalence of sarcopenia rises substantially and is associated with higher mortality as well as loss of functional capacity in daily life, autonomy, and mobility [4,5].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Arai, H., Kritchevsky, S. B., Guralnik, J., Bauer, J. M., Pahor, M., Clark, B. C., Cesari, M., et al. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1139-9 · Cited by 1,130
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Yuan, S., & Larsson, S. C. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155533 · Cited by 1,114 · cited 1×
“Our findings align with prior systematic reviews (54–60) that reported sarcopenia as a risk factor for adverse outcomes.”
MOOSE Reporting Guidelines for Meta-analyses of Observational Studies
Brooke, B. S., Schwartz, T. A., & Pawlik, T. M. (2021) · JAMA Surgery · doi:10.1001/jamasurg.2021.0522 · Cited by 742
Exercise for sarcopenia in older people: A systematic review and network meta‐analysis
Shen, Y., Shi, Q., Nong, K., Li, S., Yue, J., Huang, J., Dong, B., Beauchamp, M., & Hao, Q. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13225 · Cited by 464
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis
Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A. (2023) · Nutrients · doi:10.3390/nu15081853 · Cited by 165
Cawthon, P. M., Blackwell, T., Cummings, S. R., Orwoll, E. S., Duchowny, K. A., Kado, D. M., Stone, K. L., Ensrud, K. E., Cauley, J. A., & Evans, W. J. (2021) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa111 · Cited by 105
Cuyul-Vásquez, I., Pezo-Navarrete, J., Vargas-Arriagada, C., Ortega-Díaz, C., Sepúlveda-Loyola, W., Hirabara, S. M., & Marzuca-Nassr, G. N. (2023) · Nutrients · doi:10.3390/nu15153424 · Cited by 56
Research works printed but not linked: 59
- Cruz-Jentoft, 2019, Sarcopenia: revised European consensus on definition and diagnosis, Age Ageing, 48, 601, 10.1093/ageing/afz046 · DOI · Paper page
- Liu, 2021, Expert consensus on diagnosis and treatment of sarcopenia in Chinese elderly (2021), Chin J Geriatr, 40, 943
- Liu, 2024, Frontiers in sarcopenia: advancements in diagnostics, molecular mechanisms, and therapeutic strategies, Mol Asp Med, 97, 101270, 10.1016/j.mam.2024.101270 · DOI
- Supriya, 2021, A multifactorial approach for sarcopenia assessment: a literature review, Biology, 10, 10.3390/biology10121354 · DOI
- Yu, 2021, Chinese expert consensus on core messages for prevention of hypomyelitis in older adults (2021), Chin J Geriatr, 40, 953
- Beaudart, 2017, Health outcomes of sarcopenia: a systematic review and Meta-analysis, PLoS One, 12, e0169548, 10.1371/journal.pone.0169548 · DOI · Paper page
- Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Sterne, 2011, Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials, BMJ, 343, d4002, 10.1136/bmj.d4002 · DOI · Paper page
- De Santana, 2019, Association of appendicular lean mass, and subcutaneous and visceral adipose tissue with mortality in older Brazilians: the São Paulo Ageing & Health Study, J Bone Miner Res, 34, 1264, 10.1002/jbmr.3710 · DOI
- Yamaguchi, 2023, Association of sarcopenia and systolic blood pressure with mortality: a 5-year longitudinal study, Arch Gerontol Geriatr, 110, 104988, 10.1016/j.archger.2023.104988 · DOI
- Tanimoto, 2013, Association of sarcopenia with functional decline in community-dwelling elderly subjects in J apan, Geriatr Gerontol Int, 13, 958, 10.1111/ggi.12037 · DOI · Paper page
- Lenchik, 2021, Automated muscle measurement on chest CT predicts all-cause mortality in older adults from the National Lung Screening Trial, J Gerontol A Biol Sci Med Sci, 76, 277, 10.1093/gerona/glaa141 · DOI
- Björkman, 2019, Bioimpedance analysis and physical functioning as mortality indicators among older sarcopenic people, Exp Gerontol, 122, 42, 10.1016/j.exger.2019.04.012 · DOI
- Yao, 2024, Clinical, functional, and opportunistic CT metrics of sarcopenia at the point of imaging care: analysis of all-cause mortality, Skeletal Radiol, 53, 515, 10.1007/s00256-023-04438-w · DOI
- Oh, 2023, Combinations of sarcopenia diagnostic criteria by Asian working Group of Sarcopenia (AWGS) 2019 guideline and incident adverse health outcomes in community-dwelling older adults, J Am Med Dir Assoc, 24, 1185, 10.1016/j.jamda.2023.04.005 · DOI
- Jang, 2018, Comparisons of predictive values of sarcopenia with different muscle mass indices in Korean rural older adults: a longitudinal analysis of the aging study of PyeongChang rural area, Clin Interv Aging, 13, 91, 10.2147/CIA.S155619 · DOI · Paper page
- Chiba, 2021, Difference in sarcopenia characteristics associated with physical activity and disability incidences in older adults, J Cachexia Sarcopenia Muscle, 12, 1983, 10.1002/jcsm.12801 · DOI
- Ishii, 2020, Effects of comorbid physical frailty and low muscle mass on incident disability in community-dwelling older adults: a 24-month follow-up longitudinal study, Maturitas, 139, 57, 10.1016/j.maturitas.2020.04.018 · DOI
- Tang, 2018, FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan longitudinal aging study, J Gerontol A Biol Sci Med Sci, 73, 828, 10.1093/gerona/glx148 · DOI
- Thompson, 2021, Frailty and sarcopenia in combination are more predictive of mortality than either condition alone, Maturitas, 144, 102, 10.1016/j.maturitas.2020.11.009 · DOI
- Peng, 2023, Grip strength and sarcopenia predict 2-year cognitive impairment in community-dwelling older adults, J Am Med Dir Assoc, 24, 292, 10.1016/j.jamda.2022.10.015 · DOI
- Costanzo, 2020, Impact of low muscle mass and low muscle strength according to EWGSOP2 and EWGSOP1 in community-dwelling older people, J Gerontol A Biol Sci Med Sci, 75, 1324, 10.1093/gerona/glaa063 · DOI
- Shim, 2025, Impact of sarcopenia on falls, mobility limitation, and mortality using the diagnostic criteria proposed in the Korean working group on sarcopenia guideline, Ann Geriatr Med Res, 29, 38, 10.4235/agmr.24.0131 · DOI
- Li, 2022, Independent and joint associations of skeletal muscle mass and physical performance with all-cause mortality among older adults: a 12-year prospective cohort study, BMC Geriatr, 22, 597, 10.1186/s12877-022-03292-0 · DOI
- Liang, 2023, Long-term mortality risk in older adults with sarcopenia: an 11-year prospective cohort study comparing AWGS 2014 and AWGS 2019 guidelines for enhanced clinical utility and accurate risk prediction, J Nutr Health Aging, 27, 507, 10.1007/s12603-023-1940-y · DOI
- Amigues, 2013, Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: the prospective EPIDOS study, J Am Med Dir Assoc, 14, 352, 10.1016/j.jamda.2012.12.002 · DOI
- Balogun, 2017, Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults, J Nutr Health Aging, 21, 843, 10.1007/s12603-016-0843-6 · DOI · Paper page
- Ramoo, 2024, Sarcopenia and all-cause mortality risk in community-dwelling rural malaysian older adults, Asia Pac J Public Health, 36, 225, 10.1177/10105395241237811 · DOI
- Uemura, 2019, Sarcopenia and low serum albumin level synergistically increase the risk of incident disability in older adults, J Am Med Dir Assoc, 20, 90, 10.1016/j.jamda.2018.06.011 · DOI
- Brown, 2016, Sarcopenia and mortality among a population-based sample of community-dwelling older adults, J Cachexia Sarcopenia Muscle, 7, 290, 10.1002/jcsm.12073 · DOI · Paper page
- Pereira, 2022, Sarcopenia and mortality risk in community-dwelling brazilian older adults, Sci Rep, 12, 17531, 10.1038/s41598-022-22153-9 · DOI
- Pérez-Zepeda, 2017, Sarcopenia and post-hospital outcomes in older adults: a longitudinal study, Arch Gerontol Geriatr, 69, 105, 10.1016/j.archger.2016.10.013 · DOI
- Bachettini, 2020, Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the european working group on sarcopenia in older people, Eur J Clin Nutr, 74, 573, 10.1038/s41430-019-0508-8 · DOI
- Yuki, 2017, Sarcopenia based on the Asian working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults, Geriatr Gerontol Int, 17, 1642, 10.1111/ggi.12946 · DOI
- Sim, 2019, Sarcopenia definitions and their associations with mortality in older Australian women, J Am Med Dir Assoc, 20, 76, 10.1016/j.jamda.2018.10.016 · DOI
- Takahashi, 2021, Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus, Front Endocrinol, 12, 783363, 10.3389/fendo.2021.783363 · DOI
- Hirani, 2015, Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the Concord health and ageing in men project, J Am Med Dir Assoc, 16, 607, 10.1016/j.jamda.2015.02.006 · DOI · Paper page
- Frisoli Junior, 2025, Sarcopenia predicts mortality in older adults with cardiovascular disease: concordant findings from SDOC and EWGSOP II criteria despite limited role of low lean mass, Maturitas, 199, 108618, 10.1016/j.maturitas.2025.108618 · DOI
- Sobestiansky, 2019, Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85–89 year old community-dwelling men: a report from the ULSAM study, BMC Geriatr, 19, 318, 10.1186/s12877-019-1338-1 · DOI
- Wang, 2019, Skeletal muscle mass as a mortality predictor among nonagenarians and centenarians: a prospective cohort study, Sci Rep, 9, 2420, 10.1038/s41598-019-38893-0 · DOI · Paper page
- Ulugerger Avci, 2023, The impact of sarcopenia and obesity on mortality of older adults: five years results, Ir J Med Sci (1971 -), 192, 2209, 10.1007/s11845-023-03392-9 · DOI
- Uemura, 2018, The impact of sarcopenia on incident homebound status among community-dwelling older adults: a prospective cohort study, Maturitas, 113, 26, 10.1016/j.maturitas.2018.03.007 · DOI
- Zhang, 2023, The longitudinal bidirectional association between sarcopenia and cognitive function in community-dwelling older adults: findings from the China health and retirement longitudinal study, J Glob Health, 13, 04182, 10.7189/jogh.13.04182 · DOI
- Locquet, 2019, Three-year adverse health consequences of sarcopenia in community-dwelling older adults according to 5 diagnosis definitions, J Am Med Dir Assoc, 20, 43, 10.1016/j.jamda.2018.06.004 · DOI
- Chen, 2019, Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia, J Am Med Dir Assoc, 20, 64, 10.1016/j.jamda.2018.07.017 · DOI
- Nakano, 2024, Effect of osteosarcopenia on longitudinal mortality risk and chronic kidney disease progression in older adults, Bone, 179, 116975, 10.1016/j.bone.2023.116975 · DOI
- Zuo, 2023, Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 1183, 10.1002/jcsm.13221 · DOI · Paper page
- Shu, 2022, Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 145, 10.1002/jcsm.12890 · DOI · Paper page
- Fang, 2023, The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 3, 10.1002/jcsm.13126 · DOI
- Peng, 2020, Sarcopenia and cognitive impairment: a systematic review and meta-analysis, Clin Nutr Edinb Scotl, 39, 2695, 10.1016/j.clnu.2019.12.014 · DOI · Paper page
- Beaudart, 2023, Sarcopenia and health-related quality of life: a systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 14, 1228, 10.1002/jcsm.13243 · DOI · Paper page
- Li, 2022, Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis, J Cachexia Sarcopenia Muscle, 13, 128, 10.1002/jcsm.12908 · DOI · Paper page
- Cheng, 2021, The optimal strategy of vitamin D for sarcopenia: a network Meta-analysis of randomized controlled trials, Nutrients, 13, 10.3390/nu13103589 · DOI · Paper page
- De Felice, 2025, Progress and challenges in integrating nutritional care into oncology practice: results from a National Survey on behalf of the NutriOnc research group, Nutrients, 17, 188, 10.3390/nu17010188 · DOI
- Hämäläinen, 2025, Effects of 12-month physical and cognitive training on sarcopenia determinants in older adults: a subgroup analysis of a randomised clinical trial, Aging Clin Exp Res, 37, 36, 10.1007/s40520-025-02935-7 · DOI
- Zhu, 2025, Exploring the mediating roles of depression and cognitive function in the association between sarcopenia and frailty: a cox survival analysis approach, J Adv Res, 76, 605, 10.1016/j.jare.2024.12.021 · DOI
Cited by
Büntzel, S. K., Büthe, L., Sulzer, S., Büntzel, J., & Büntzel, J. (2026) · Nutrients · doi:10.3390/nu18213550
Metadata
- Authors
- Zhao, Y., Jiang, Y., Guo, Y., Pan, W., Tian, W., Tang, L., & Feng, X.
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2026-01-08
- Volume
- 12
- ISSN
- 2296-861X
- Cited by
- 19
- References
- 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.